Article: Martek Releases 3Q 2009 Financial Results.

Martek Biosciences Corp. announced its financial results for the third quarter of fiscal 2009.

In a release on September 2, the Company noted that revenues for the third quarter were $77.8 million, down 12 percent from $88.4 million in the third quarter of fiscal 2008.

Net income was $8.9 million, or $0.27 per diluted share, for the third quarter of fiscal 2009, a 4 percent decrease compared with $9.3 million, or $0.28 per diluted share, in last year's third quarter.

Commenting on the quarter, Chief Executive Officer Steve Dubin said, "Martek's third quarter 2009 financial results benefited from a 41 percent quarter over quarter increase in ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!